Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Tumbarello

Showing results (111-120 of 197) with videos related to

Pageof 20
Sort By:
Journal of Critical Care|December 16, 2018
Risk factors for mortality and cost implications of complicated intra-abdominal infections in critically ill patientsGennaro De Pascale, Simone Carelli, Maria Sole Vallecoccia, et al.
Intensive Care Medicine|March 21, 2015
Preventive and therapeutic strategies in critically ill patients with highly resistant bacteriaMatteo Bassetti, Jan J De Waele, Philippe Eggimann, et al.
Journal of Clinical Microbiology|October 11, 2013
Epidemiology, species distribution, antifungal susceptibility, and outcome of candidemia across five sites in Italy and SpainMatteo Bassetti, Maria Merelli, Elda Righi, et al.
European Journal of Clinical Investigation|February 9, 2019
Fungaemia in haematological malignancies: SEIFEM-2015 surveyMarianna Criscuolo, Francesco Marchesi, Anna Candoni, et al.
Journal of Chemotherapy (Florence, Italy)|April 6, 2017
Diagnosis and management of skin and soft-tissue infections (SSTI). A literature review and consensus statement: an updateSilvano Esposito, Matteo Bassetti, Ercole Concia, et al.
Viruses|May 27, 2023
Efficacy and Durability of Dolutegravir- or Darunavir-Based Regimens in ART-Naïve AIDS- or Late-Presenting HIV-Infected PatientsMassimiliano Fabbiani, Melissa Masini, Barbara Rossetti, et al.
Infectious Diseases and Therapy|August 7, 2025
Can We Lower the Burden of Antimicrobial Resistance (AMR) in Heavily Immunocompromised Patients? A Narrative Review and Call to ActionMatteo Bassetti, Antonella Cardone, Fatima Cardoso, et al.
The Journal of Antimicrobial Chemotherapy|December 14, 2012
Mortality in patients with early- or late-onset candidaemiaFrancesco Giuseppe De Rosa, Enrico Maria Trecarichi, Chiara Montrucchio, et al.
Antimicrobial Agents and Chemotherapy|April 22, 2015
Antifungal susceptibility profiles of bloodstream yeast isolates by Sensititre YeastOne over nine years at a large Italian teaching hospitalBrunella Posteraro, Teresa Spanu, Barbara Fiori, et al.
Infection and Drug Resistance|May 24, 2019
Direct use of eazyplex<sup>®</sup> SuperBug CRE assay from positive blood cultures in conjunction with inpatient infectious disease consulting for timely appropriate antimicrobial therapy in <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> bloodstream infectionsBarbara Fiori, Tiziana D'Inzeo, Brunella Posteraro, et al.
Pageof 20

Showing results (111-120 of 197) with videos related to

Sort By:
Pageof 20
Journal of Critical Care|December 16, 2018
Risk factors for mortality and cost implications of complicated intra-abdominal infections in critically ill patientsGennaro De Pascale, Simone Carelli, Maria Sole Vallecoccia, et al.
Intensive Care Medicine|March 21, 2015
Preventive and therapeutic strategies in critically ill patients with highly resistant bacteriaMatteo Bassetti, Jan J De Waele, Philippe Eggimann, et al.
Journal of Clinical Microbiology|October 11, 2013
Epidemiology, species distribution, antifungal susceptibility, and outcome of candidemia across five sites in Italy and SpainMatteo Bassetti, Maria Merelli, Elda Righi, et al.
European Journal of Clinical Investigation|February 9, 2019
Fungaemia in haematological malignancies: SEIFEM-2015 surveyMarianna Criscuolo, Francesco Marchesi, Anna Candoni, et al.
Journal of Chemotherapy (Florence, Italy)|April 6, 2017
Diagnosis and management of skin and soft-tissue infections (SSTI). A literature review and consensus statement: an updateSilvano Esposito, Matteo Bassetti, Ercole Concia, et al.
Viruses|May 27, 2023
Efficacy and Durability of Dolutegravir- or Darunavir-Based Regimens in ART-Naïve AIDS- or Late-Presenting HIV-Infected PatientsMassimiliano Fabbiani, Melissa Masini, Barbara Rossetti, et al.
Infectious Diseases and Therapy|August 7, 2025
Can We Lower the Burden of Antimicrobial Resistance (AMR) in Heavily Immunocompromised Patients? A Narrative Review and Call to ActionMatteo Bassetti, Antonella Cardone, Fatima Cardoso, et al.
The Journal of Antimicrobial Chemotherapy|December 14, 2012
Mortality in patients with early- or late-onset candidaemiaFrancesco Giuseppe De Rosa, Enrico Maria Trecarichi, Chiara Montrucchio, et al.
Antimicrobial Agents and Chemotherapy|April 22, 2015
Antifungal susceptibility profiles of bloodstream yeast isolates by Sensititre YeastOne over nine years at a large Italian teaching hospitalBrunella Posteraro, Teresa Spanu, Barbara Fiori, et al.
Infection and Drug Resistance|May 24, 2019
Direct use of eazyplex<sup>®</sup> SuperBug CRE assay from positive blood cultures in conjunction with inpatient infectious disease consulting for timely appropriate antimicrobial therapy in <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> bloodstream infectionsBarbara Fiori, Tiziana D'Inzeo, Brunella Posteraro, et al.
Pageof 20